Zobrazeno 1 - 10
of 297
pro vyhledávání: '"Masahiro, Kizaki"'
Autor:
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1244-1254 (2022)
Introduction Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs).Materials and methods We retrospectively analysed the clinical featu
Externí odkaz:
https://doaj.org/article/2e6495f34fd84e83afef69bd99b33b59
Autor:
Morihiro Higashi, Shuji Momose, Natsuko Takayanagi, Yuka Tanaka, Tomoe Anan, Takahisa Yamashita, Jun Kikuchi, Michihide Tokuhira, Masahiro Kizaki, Jun‐ichi Tamaru
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 4, Pp 340-354 (2022)
Abstract The tumor microenvironment (TME) is a critical regulator of the development of malignant lymphoma. Therapeutics targeting the TME, especially immune checkpoint molecules, are changing the treatment strategy for lymphoma. However, the overall
Externí odkaz:
https://doaj.org/article/8594462fbdb746138b9217549f353d34
Autor:
Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Publikováno v:
Blood. 140:8634-8637
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f59f571029572beba1d0721cfa24ae76
https://doi.org/10.1182/blood-2022-162895
https://doi.org/10.1182/blood-2022-162895
Autor:
Kavita Umrau, Ken Naganuma, Qi Gao, Ahmet Dogan, Masahiro Kizaki, Mikhail Roshal, Ying Liu, Mariko Yabe
Publikováno v:
Leukemia & Lymphoma. 64:238-241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2af761b11c80ac75cbedc0a7d0ad5515
https://doi.org/10.1080/10428194.2022.2131413
https://doi.org/10.1080/10428194.2022.2131413
Autor:
Takayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, Naoko Hosono, Yasuyoshi Morita, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, Keisuke Matsubara, Saori Sugimoto, Yasushi Miyazaki, Masahiro Kizaki, Koichi Akashi
Publikováno v:
Cancer Science. 113:4258-4266
Therapeutic improvements are needed for patients with acute myeloid leukemia (AML), particularly those who have relapsed or who have treatment-refractory (R/R) AML or newly diagnosed patients with poor prognostic factors. Alvocidib (DSP-2033), a pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e60e8cc6a916c28c54f4d279a39f0a86
https://doi.org/10.1111/cas.15458
https://doi.org/10.1111/cas.15458
Publikováno v:
Future Oncology. 18:2661-2674
Carfilzomib is a medicine that was recently approved for the treatment of cancer of bone marrow (multiple myeloma) that comes back or does not respond to previous treatment (relapsed or refractory). Data gathered from the hospitals, where the medicin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f941ed1c68c3670e9e1fcf6a5b00b5fd
https://doi.org/10.2217/fon-2022-0259
https://doi.org/10.2217/fon-2022-0259
Autor:
Michihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, Naoki Watanabe, Shun Tsuchiya, Tomoiku Takaku, Noriyoshi Iriyama, Eriko Sato, Tomonori Nakazato, Toru Mitsumori, Maho Ishikawa, Hiroyuki Fujita, Masahiro Kizaki, Miki Ando, Yoshihiro Hatta, Eisaku Iwanaga, Tatsuya Kawaguchi
Publikováno v:
International Journal of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4348e931da8d4acb898ea11cdf8aec40
https://doi.org/10.1007/s12185-023-03606-x
https://doi.org/10.1007/s12185-023-03606-x
Autor:
Kenneth C. Anderson, Teru Hideshima, Masahiro Kizaki, Nikhil C. Munshi, Yu-Tzu Tai, Mehmet K. Samur, Takeshi Harada, Hiroto Ohguchi, Morihiko Sagawa
Survival analysis of RRM1 and RRM2 in newly diagnosed MM patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe6f7b9e262814eed6e7287c7205c97
https://doi.org/10.1158/1078-0432.22466816.v1
https://doi.org/10.1158/1078-0432.22466816.v1
Autor:
Kenneth C. Anderson, Teru Hideshima, Masahiro Kizaki, Nikhil C. Munshi, Yu-Tzu Tai, Mehmet K. Samur, Takeshi Harada, Hiroto Ohguchi, Morihiko Sagawa
Primers for quantitative real-time polymerase chain reaction (QRT-PCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e5ec4b7689915dd378635e3ad617302
https://doi.org/10.1158/1078-0432.22466807
https://doi.org/10.1158/1078-0432.22466807
Autor:
Kenneth C. Anderson, Teru Hideshima, Masahiro Kizaki, Nikhil C. Munshi, Yu-Tzu Tai, Mehmet K. Samur, Takeshi Harada, Hiroto Ohguchi, Morihiko Sagawa
Supplementary Figure Legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::def277091f181015e8783f24b791f669
https://doi.org/10.1158/1078-0432.22466822
https://doi.org/10.1158/1078-0432.22466822